Back
Verisk Analytics Vs. Keros Therapeutics Industry Stock Comparison
Buy
89
VRSK
Verisk Analytics
Last Price:
269.35
Seasonality Move:
4.73%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.41
Seasonality Move:
4.22%
Buy
89
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
- The current Verisk Analytics [VRSK] share price is $272.28. The Score for VRSK is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- VRSK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $272.28
The current trend is moderately bullish and VRSK is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.65 | Buy |
Relative Strength Index (14 RSI): | 76.1 | Buy |
Chaikin Money Flow: | 49417 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (251.79 - 267.49) | Buy |
Bollinger Bands (100): | (228.91 - 255.83) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.91 | Sell |
Relative Strength Index (14 RSI): | 36.74 | Sell |
Chaikin Money Flow: | -120480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.18 - 50.06) | Sell |
Bollinger Bands (100): | (50.42 - 64.92) | Sell |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 268.19 | Buy |
20-day SMA: | 261.63 | Buy |
50-day SMA: | 246.6 | Buy |
200-day SMA: | 240.34 | Buy |
8-day EMA: | 268.62 | Buy |
20-day EMA: | 262.58 | Buy |
50-day EMA: | 252.3 | Buy |
200-day EMA: | 238.36 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.5 | Sell |
20-day SMA: | 47.57 | Sell |
50-day SMA: | 52.43 | Sell |
200-day SMA: | 46.94 | Sell |
8-day EMA: | 46.46 | Sell |
20-day EMA: | 48 | Sell |
50-day EMA: | 51.59 | Sell |
200-day EMA: | 50.14 | Sell |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.21 per share, an increase this year of $0.81 per share, and an increase next year of $0.83 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Verisk Analytics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |